On this page

1. Useful links
2. Guides and publications

Useful links

• Australian Commission on Safety and Quality in Health Care (ACSQHC)
• Australian Digital Health Agency
• Australian Government Department of Health (DoH)
• Australian Government Department of Human Services (Medicare and Pharmaceutical Benefits Scheme)
• Australian Health Practitioner Regulation Agency (AHPRA)
• Australian Self Medication Industry (ASMI)
• Australasian Legal Information Institute
• Clinical Excellence Commission (CEC)
• Dental Board of Australia
• Health Care Complaints Commission (HCCC)
• Health Professional Councils Authority (HPCA)
• HealthShare NSW (including Electronic Medical Record, Electronic Medication Management, Pharmacy Improvement Program)
• Medical Council of NSW
• Medical Board of Australia
• National Pharmaceutical Services Association (NPSA)
• National Prescribing Service (NPS)
• NSW Agency for Clinical Innovation (ACI)
• NSW Therapeutic Advisory Group Inc (TAG)
• Nursing and Midwifery Board of Australia
• Pharmacy Board of Australia
• Pharmacy Council of New South Wales
• Pharmaceutical Society of Australia (PSA)
• Royal Australian College of General Practitioners (RACGP)
• The Pharmacy Guild of Australia
• The Royal Australasian College of Physicians (RACP)
• The Society of Hospital Pharmacists of Australia (SHPA)
• Therapeutic Goods Administration (TGA)
• Veterinary Practitioners Board of NSW

Guides and publications

• Approved Systems for Recording the Supply of Substances on Prescription Generally or in an Emergency to Health Professionals
• Criteria for the Management of Medication for Attention Deficit Hyperactivity Disorder in Adults (TG190)
• Criteria for the Management of Medication for Attention Deficit Hyperactivity Disorder in Children and Adolescents (TG181)
• Drugs of Addiction (Schedule 8) (TG13)
• Electronic Form to Record Pseudoephedrine Sales (TG214)
• Electronic Medication Management System Governance and Standards (PD2019_050)
• Framework for Use of an Electronic Drug Register Requiring Dual Signatures (TG215)
• Framework for Use of an Electronic Drug Register Requiring Single Signatures (TG216)
• Framework for Use of an Electronic Drug Register Requiring Single Signature by a Licensed Wholesaler (TG217)
• Guide to Poisons and Therapeutic Goods Legislation for General Sellers of Poisons (TG9A)
• Guide to Poisons and Therapeutic Goods Legislation for Medical, Nurse and Midwife Practitioners and Dentists (TG12)
• Guide to Poisons and Therapeutic Goods Legislation for Pharmacists (TG79)
• Guide to Poisons and Therapeutic Goods Legislation for Poisons Licence Holders (TG9)
• Guide to Poisons and Therapeutic Goods Legislation for Veterinary Practitioners (TG74)
• Guide to the Handling of Medication in Nursing Homes in NSW (IB2003_10)
• Guide to the Requirements of Poisons and Therapeutic Goods Legislation for the Supply of Schedule 3 Substances (TG151)
• Guidelines for the Supply by Wholesalers of Substances in Schedule 2, 3 or 4 of the Poisons List (TG191)
• Medication Handling (PD2022_032)
• NSW Clinical Guidelines: Treatment of Opioid Dependence (GL2018_019)
• NSW Clinical Guidelines: Treatment of Opioid Dependence - Abbreviated Version (GL2018_018)
• NSW Legal Requirements for an Authority to Prescribe Drugs of Addiction
• NSW Opioid Treatment Program Community Pharmacy Dosing Protocol (TG201)
• Opioid Dependent Persons Admitted to Hospitals in NSW – Management (PD2006_049)
• Preparation of pharmaceutical and advanced therapeutic products (PD2023_021)
• NSW Therapeutic Advisory Group Guidelines: Preventing and Managing Problems with Opioid Prescribing for Chronic Non-Cancer Pain
• Recognising and Managing Drug Dependent Persons - Notes for Medical Practitioners (TG116A)
• Schedule 4 Appendix D Drugs ("Prescribed restricted substances")
• Summary of Controls on the Prescribing and Handling of Drugs of Dependence by Medical, Nurse and Midwife Practitioners
• Summary of Requirements for Authority to Obtain, Use or Supply Schedule 7 Poisons